ConductScience.org, home

Paper19935641

The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer.

Klintman M and 6 others. Mod Pathol, 2010. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer. Papers, record 19935641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19935641

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer.
PubMed
Journal
Mod Pathol
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
1.8
iCite
Revised in PubMed
2023-02-10
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Klintman MMarie
2Bendahl POPär-Ola
3Grabau DDorthe
4Lövgren KKristina
5Malmström PPer
6Fernö MMårten
7South Sweden Breast Cancer GroupGroup

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Breast NeoplasmsMajor topic
Ki-67 AntigenMajor topic
Adult
Disease-Free Survival
Female
Humans
Kaplan-Meier Estimate
Middle Aged
Premenopause
Prognosis
Receptors, Estrogen
Tissue Array Analysis

Source PubMed

Download CSV of topics

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
42860544Tracking CDK1 Dynamics With a Novel Biosensor Mouse and Clinical Cohorts to Predict CDK4/6 Inhibitor Sensitivity in ER+ Breast Cancer.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42860544PubMed
42243585Clinical and Pathological Characteristics and Prognosis of Breast Cancer During Pregnancy and Postpartum: A Multicenter Retrospective Study.Cancer Rep (Hoboken)2026https://conductscience.org/library/papers/42243585PubMed
42226239Breast cancer survival prediction using machine learning and multimodal data for personalized care plan.BMC Cancer2026https://conductscience.org/library/papers/42226239PubMed
37643366Clinical and Pathological Characteristics of Patients With Papillary Thyroid Carcinoma Coexisting With Hashimoto's Thyroiditis: A Retrospective Cohort Study.Cancer Control2023https://conductscience.org/library/papers/37643366PubMed
37546410FGF/FGFR1 system in paired breast tumor-adjacent and tumor tissues, associations with mammographic breast density and tumor characteristics.Front Oncol2023https://conductscience.org/library/papers/37546410PubMed
33194179A comparative study between Ki67 positive versus Ki67 negative females with breast cancer: Cross sectional study.Ann Med Surg (Lond)2020https://conductscience.org/library/papers/33194179PubMed
30646210Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk.JAMA Netw Open2019https://conductscience.org/library/papers/30646210PubMed
29888170Anticancer Effects of Dihydroartemisinin on Human Esophageal Cancer Cells In Vivo.Anal Cell Pathol (Amst)2018https://conductscience.org/library/papers/29888170PubMed
29348868Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis.Oncotarget2017https://conductscience.org/library/papers/29348868PubMed
29169398Identifying accessible prognostic factors for breast cancer relapse: a case-study on 405 histologically confirmed node-negative patients.World J Surg Oncol2017https://conductscience.org/library/papers/29169398PubMed
28650989Tumor tissue protein signatures reflect histological grade of breast cancer.PLoS One2017https://conductscience.org/library/papers/28650989PubMed
28298390Clinical usefulness of the free web-based image analysis application ImmunoRatio for assessment of Ki-67 labelling index in breast cancer.J Clin Pathol2017https://conductscience.org/library/papers/28298390PubMed
27703526Ki-67 is overexpressed in human laryngeal carcinoma and contributes to the proliferation of HEp2 cells.Oncol Lett2016https://conductscience.org/library/papers/27703526PubMed
27141101GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome.Mol Cancer Res2016https://conductscience.org/library/papers/27141101PubMed
26916072Digital image analysis outperforms manual biomarker assessment in breast cancer.Mod Pathol2016https://conductscience.org/library/papers/26916072PubMed
26742937Ki-67 is a prognostic marker for hormone receptor positive tumors.Clin Transl Oncol2016https://conductscience.org/library/papers/26742937PubMed
26662799Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.Tumour Biol2016https://conductscience.org/library/papers/26662799PubMed
25400769Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy.Int J Clin Exp Pathol2014https://conductscience.org/library/papers/25400769PubMed
25362932Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer.BMC Cancer2014https://conductscience.org/library/papers/25362932PubMed
24977004Evaluating the response of neoadjuvant chemotherapy for treatment of breast cancer: are tumor biomarkers and dynamic contrast enhanced MR images useful predictive tools?J Thorac Dis2014https://conductscience.org/library/papers/24977004PubMed

See all 31 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
MKI674288PubTator's text mininghttps://conductscience.org/library/genes/4288NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19935641

GET https://conductscience.org/api/papers/v1/19935641/cited_by?page=2